Carmel Capital Partners LLC Raises Holdings in Agilent Technologies, Inc. (NYSE:A)

Carmel Capital Partners LLC boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 11.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,943 shares of the medical research company’s stock after purchasing an additional 788 shares during the quarter. Carmel Capital Partners LLC’s holdings in Agilent Technologies were worth $1,067,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $48,172,000. Aigen Investment Management LP acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $302,000. Proficio Capital Partners LLC acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $26,066,000. Assetmark Inc. boosted its position in shares of Agilent Technologies by 31.7% during the 4th quarter. Assetmark Inc. now owns 135,108 shares of the medical research company’s stock worth $18,150,000 after acquiring an additional 32,547 shares in the last quarter. Finally, Triad Wealth Partners LLC acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $256,000.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on A. Bank of America lowered their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Citigroup upped their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Wells Fargo & Company decreased their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Finally, Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Stock Up 2.9 %

Agilent Technologies stock opened at $126.64 on Thursday. Agilent Technologies, Inc. has a twelve month low of $121.45 and a twelve month high of $155.35. The stock has a 50 day moving average of $140.03 and a two-hundred day moving average of $138.87. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $36.11 billion, a price-to-earnings ratio of 29.11, a PEG ratio of 3.45 and a beta of 1.11.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.